AngioDynamics Port Catheter Lawsuit

The AngioDynamics Port Catheter Products Liability Litigation has been consolidated into a Multidistrict Litigation (MDL No. 3125) in the U.S. District Court for the Southern District of California.

This centralization, established on October 3, 2024, by the United States Judicial Panel on Multidistrict Litigation, aims to streamline the legal process for numerous similar cases across the country.

Allegations Against Device Manufacturers

The primary defendants in this litigation are AngioDynamics, Inc., and Navilyst Medical, Inc., the manufacturers and distributors of the implantable port catheter devices.

The key allegations against these companies include:

• Defective design of port catheter devices
• Use of excessive concentrations of barium sulfate in catheter manufacturing
• Failure to adequately warn healthcare providers and patients of potential risks
• Insufficient pre-market testing to identify potential complications
• Negligence in the production and quality control of the devices

Plaintiffs argue that these alleged shortcomings have led to serious health complications for patients who received the AngioDynamics port catheters.

Individual Injury Claims Reported

The consolidation of these cases into an MDL allows for more efficient handling of common factual and legal issues while still preserving the individual nature of each plaintiff’s claim.

These cases report various injuries that include, but are not limited to:

• Catheter fracture and migration
• Severe infections at the implant site
• Formation of blood clots (thrombosis)
• Perforation of blood vessels or organs
• Need for additional surgeries to remove or replace the device
• Chronic pain and discomfort

As the litigation progresses, it is expected that more patients may come forward with similar allegations, potentially expanding the scope of the MDL.

The health complications reportedly associated with AngioDynamics port catheters have raised serious concerns within the medical community and among patients.

These issues range from immediate post-implantation problems to long-term health risks, potentially affecting the quality of life and overall health outcomes for patients who received these devices.

Risks of Medical Device: Barium Sulfate

AngioDynamics port catheters contain barium sulfate, a substance used to make the devices visible on X-rays.

While barium sulfate is commonly used in medical imaging, its presence in implantable devices has raised concerns.

Patients have reported the following adverse reactions:

• Allergic reactions:
• Inflammation at the implant site:
• Formation of granulomas (small areas of inflammation):
• Potential long-term toxicity concerns:

Legal experts are investigating whether AngioDynamics performed adequate research or disclosed the potential risks associated with long-term exposure to barium sulfate in implanted devices.

Research Indicatin Elevated Thrombosis Risk

One of the most significant concerns surrounding AngioDynamics port catheters is the reportedly increased risk of thrombosis or blood clot formation.

Several studies have suggested that these devices may be associated with a higher incidence of catheter-related thrombosis compared to other similar products on the market.

Key points from recent research include:

• Incidence and Clinical Significance: Symptomatic thromboembolic complications occur in ≤5% of oncology patients with CVCs. Asymptomatic CVC-related thrombi are common; clinical significance is unclear.
• Risk Factors: Increased risk from thrombophilic disorders (e.g., factor V Leiden mutation). Other risk factors include thrombogenic material, larger diameter, more lumens, malposition, left-side placement, multiple insertions, previous CVC, venous obstruction, prothrombotic agents, infections, and lumen occlusion.
• Thromboprophylaxis: Routine low-dose warfarin/heparin was not beneficial for general oncology patients. Thromboprophylaxis may be safe for high-risk patients.
• Diagnosis: Duplex ultrasound detects thrombi in jugular, axillary, subclavian, and arm veins. Contrast venography is needed for unclear duplex results and deep vein evaluation.
• Treatment: Anticoagulation, with/without catheter removal, is used for DVT or pulmonary embolism without contraindications. Catheter removal alone may suffice if the bleeding risk is high.

Thrombosis can lead to serious complications, including pulmonary embolism, stroke, need for anticoagulation therapy, and catheter malfunction requiring removal and replacement.

The MDL proceedings are expected to examine the scientific evidence regarding thrombosis risk and determine whether AngioDynamics failed in its duty to warn about this potential complication.

If you or a loved one suffered injuries or complications due to an AngioDynamics port catheter, you may be eligible to pursue legal compensation.

These lawsuits often involve claims of product defects, inadequate warnings, or medical complications caused by faulty designs.

Below, we outline key steps and criteria to assist you with filing an AngioDynamics port catheter lawsuit.

Collecting Evidence for Port Catheter Legal Claims

Strong evidence is crucial when pursuing compensation for injuries linked to a defective medical device like the AngioDynamics port catheter.

The evidence you provide can help demonstrate the extent of your injuries, the defect in the device, and the resulting financial or physical damages.

To support your legal claim, consider gathering the following types of evidence:

• Medical Records: Obtain documentation of your diagnosis, treatments, and any complications related to the port catheter.
• Device Information: Retain any packaging, labels, or instructions provided with the catheter.
• Incident Reports: If applicable, request reports from hospitals or healthcare providers detailing issues encountered with the catheter.
• Expert Testimony: Work with medical professionals to provide expert opinions on the device’s defect and its impact on your health.
• Financial Documentation: Keep records of medical bills, lost wages, and other financial losses related to your injury.

Thorough documentation can significantly strengthen your case by providing a clear narrative of how the device caused or contributed to your injury.

Legal counsel can help you determine which evidence is most critical based on your specific circumstances.

Eligibility Criteria to File an AngioDynamics Port Catheter Lawsuit

Not everyone impacted by a medical device is eligible to file a lawsuit. Eligibility typically depends on several legal and medical factors.

These criteria help courts determine whether the injury is actionable under product liability laws.

To determine if you may be eligible to file an AngioDynamics port catheter lawsuit, the following criteria are often considered:

1. Injury or Complication: You must have experienced a medically diagnosed injury or complication linked to the use of an AngioDynamics port catheter.
2. Defective Product: There must be evidence suggesting that the catheter had a design flaw, manufacturing defect, or insufficient warning labels.
3. Causation: Your legal claim must establish that the defective catheter directly caused or worsened your injury.
4. Statute of Limitations: Your claim must be filed within the applicable statute of limitations, which varies by state and can range from one to several years after the injury occurred or was discovered.

If successful, a lawsuit related to injuries caused by an AngioDynamics port catheter may compensate for various damages, both economic and non-economic.

Plaintiffs often claim that defective port catheters result in severe complications, such as infections, device fractures, and vascular damage.

These complications can lead to prolonged medical care, pain, and significant financial losses. Courts and settlements assess the nature and severity of the harm to determine the types and amount of compensation awarded.

Types of Potential Damages

Individuals pursuing legal action against AngioDynamics may be eligible to seek compensation for the following damages:

• Medical Expenses: Reimbursement for past, current, and future medical treatments related to complications from the port catheter.
• Lost Wages: Compensation for income lost due to time away from work during recovery or treatment.
• Pain and Suffering: Non-economic damages for physical pain and emotional distress caused by the injury.
• Loss of Consortium: Compensation for the impact on relationships, including loss of companionship or spousal support, if applicable.
• Permanent Disability: Damages for long-term or permanent physical impairments resulting from the injury.
• Punitive Damages: In some cases, courts may award punitive damages if there is evidence of reckless or intentional misconduct by the manufacturer.

Medical Complications Linked to AngioDynamics Port Catheter

Defective or improperly designed port catheters can lead to several health complications that justify claims for damages, including:

• Catheter migration or device fracture within the body
• Severe bloodstream infections (sepsis)
• Blood clots or thrombosis
• Damage to veins or surrounding organs
• Pain and discomfort requiring device removal

These complications can result in long-term health consequences, which may significantly affect the plaintiff’s quality of life and financial stability.

How Compensation is Determined

The amount and types of damages awarded vary based on the unique facts of each case. Factors influencing compensation may include:

• Severity of Injury: Cases involving permanent disability or life-threatening conditions typically result in higher awards.
• Extent of Financial Loss: Courts assess the costs of medical treatment, lost wages, and other economic impacts.
• Pain and Suffering: Non-economic damages are evaluated based on the level of pain, emotional trauma, and disruption to the plaintiff’s life.
• Manufacturer Liability: If evidence shows that AngioDynamics failed to warn consumers or acted negligently in designing the port catheter, punitive damages may be imposed.

Seeking legal advice early in the process can help plaintiffs understand their rights and the potential value of their claim.

Legal professionals can also provide guidance on documenting injuries and losses to maximize compensation.

AngioDynamics port catheter lawsuits are being filed by individuals across the country who were injured by defective port catheters.

TruLaw is currently accepting clients for the AngioDynamics port catheter lawsuit.

A few reasons to choose TruLaw for your AngioDynamics port catheter lawsuit include:

• If We Don’t Win, You Don’t Pay: The medical device lawyers at TruLaw and our partner firms operate on a contingency fee basis, meaning we only get paid if you win.
• Expertise: We have years of experience handling medical device cases similar to the AngioDynamics port catheter lawsuit, which helps us anticipate what we can expect to see in your case and the regulations we will be required to meet.
• Successful Track Record: TruLaw and our partner law firms have helped our clients recover billions of dollars in compensation through verdicts and negotiated settlements.

If you or a loved one suffered complications or injuries related to a defective AngioDynamics port catheter, you may be eligible to seek compensation.

Contact TruLaw using the chat on this page to receive an instant case evaluation that can determine if you qualify for the AngioDynamics Port Catheter lawsuit today.